3Menzies-Gow A,Robinson DS. Eosinophils 6osinophilis Cytokines (interleukin-5 ), and antieosinophilic therapy in asthma. Curr Opin Med, 2002,8 : 33-38.
4Barnes PJ, Karin M. Nuclear factor-κB -A pivotal transcription factor in chronic inflammation diseases. N Eng J Med, 1997,10:1066-1071.
5Ying S, Humbert M,Barkans J,et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4^- and CD8^+ T cells,cosinophds, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol, 1997,158;3539-3544.
6Kampen GT, Stafford S, Adachi T. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen- activated protein kinases.Blood,2000,95 : 1911-1917.
7Han SJ, Kim JH, Noh YJ, el al. Interleukin (IL)-5 downregulates tumor necrosis factor (TNF)-induced eotaxin messenger RNA (mRNA) expression in eosinophils. Induction of eotaxin mRNA by TNF and IL-5 in eosinophils. Am J Respir Cell Mol Biol,1999,21:303-310.
8Nakajima T, Yamada H. I.ikura M, et al. Intracellular localization and release of eotaxin from normal eosinophils.FEBS Lett, 1998,434:226-230.
9Nickel R, Barnes KC, Sengler CA, et al. Evidence for linkage of chemokine polymorphisms to asthma in populatinons of Aferican descent, Allergy Clin Immunol, 1999,103 :S174.
10Matsumoto K, Saito H . The role of eosinophils in asthma:Sarastro or the Queen of the Night? Int Arch Allergy Immunol.2001.125:290 296.
